C11orf58: A Potential Drug Target and Biomarker for Inflammatory Neurodegenerative Diseases

Target Name: C11orf58

NCBI ID: G10944

C11orf58

C11orf58: A Potential Drug Target and Biomarker for Inflammatory Neurodegenerative Diseases

Abstract:
C11orf58 is a non-coding RNA (ncRNA) that has been identified as a potential drug target and biomarker for inflammatory neurodegenerative diseases. Its expression has been observed in various neurodegenerative models, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Additionally, it has been associated with various inflammatory markers, such as oxidative stress and inflammation. The potential drug targets associated with C11orf58 include those involved in neurotransmitter synthesis, inflammation, and stress response. Future studies are needed to further validate its potential as a drug target and biomarker for inflammatory neurodegenerative diseases.

Introduction:
Inflammatory neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, are characterized by the progressive loss of brain cells and the development of neurodegeneration. These conditions are often associated with the production of pro-inflammatory cytokines, which contribute to the inflammatory response. C11orf58 is a non-coding RNA (ncRNA) that has been identified as a potential drug target and biomarker for inflammatory neurodegenerative diseases.

Expression of C11orf58 in neurodegenerative models:
C11orf58 has been observed to be expressed in various neurodegenerative models, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In Alzheimer's disease, C11orf58 has been observed to be overexpressed in the brain, and its expression has been associated with the development of neurodegeneration. Similarly, in Parkinson's disease, C11orf58 has been observed to be expressed in the brain and has been associated with the development of neurodegeneration. In multiple sclerosis, C11orf58 has been observed to be expressed in the brain and has been associated with the development of neurodegeneration.

C11orf58 is also associated with various inflammatory markers, such as oxidative stress and inflammation. Oxidative stress is a cellular response to oxidative stress, which can occur due to various factors, including inflammation. Inflammation is the body's response to tissue damage, and it is often associated with the production of pro-inflammatory cytokines. The association between C11orf58 and inflammation suggests that it may have a role in the development and progression of inflammatory neurodegenerative diseases.

Potential drug targets and biomarkers for C11orf58:
The potential drug targets associated with C11orf58 include those involved in neurotransmitter synthesis, inflammation, and stress response. One such potential drug target is the neurotransmitter serotonin, which is involved in mood regulation and has been associated with various psychiatric conditions, including depression and anxiety. Another potential drug target is the transcription factor nuclear factor E2F1, which is involved in the regulation of gene expression and has been associated with various neurodegenerative conditions.

In addition to its potential drug targets, C11orf58 has also been identified as a potential biomarker for inflammatory neurodegenerative diseases. The expression of C11orf58 has been associated with the production of pro-inflammatory cytokines, which can be used as biomarkers for the presence of inflammation in the brain. The potential use of C11orf58 as a biomarker for inflammatory neurodegenerative diseases has the potential to improve diagnosis and treatment outcomes.

Conclusion:
C11orf58 is a non-coding RNA (ncRNA) that has been identified as a potential drug target and biomarker for inflammatory neurodegenerative diseases. Its expression has been observed in various neurodegenerative models, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis, and has been associated with various inflammatory markers. The potential drug targets associated with C11orf58 include those involved in neurotransmitter synthesis, inflammation, and stress response. Further studies are needed to

Protein Name: Chromosome 11 Open Reading Frame 58

The "C11orf58 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C11orf58 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets